AWK vs DMAC
American Water Works (AWK) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
DMAC does not have a complete income-statement cache yet.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the AWK and DMAC stock pages for the full models.
Not investment advice.